These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 8898173)
21. Expression of interleukin-6, interleukin-6 receptor, and glycoprotein 130 correlates with good prognoses for patients with breast carcinoma. Karczewska A; Nawrocki S; Breborowicz D; Filas V; Mackiewicz A Cancer; 2000 May; 88(9):2061-71. PubMed ID: 10813718 [TBL] [Abstract][Full Text] [Related]
22. Cytokines involving gp130 in signal transduction suppressed growth of a mouse hybridoma cell line and enhanced its antibody production. Terada S; Suzuki E; Ueda H; Makishima F Cytokine; 1996 Dec; 8(12):889-94. PubMed ID: 9050746 [TBL] [Abstract][Full Text] [Related]
23. Reversible inhibition of IL-8 receptor B mRNA expression and proliferation in non-small cell lung cancer by antisense oligonucleotides. Olbina G; Cieslak D; Ruzdijic S; Esler C; An Z; Wang X; Hoffman R; Seifert W; Pietrzkowski Z Anticancer Res; 1996; 16(6B):3525-30. PubMed ID: 9042216 [TBL] [Abstract][Full Text] [Related]
24. Specific inhibition of IL-6 signalling with monoclonal antibodies against the gp130 receptor. Liautard J; Sun RX; Cotte N; Gaillard JP; Mani JC; Klein B; Brochier J Cytokine; 1997 Apr; 9(4):233-41. PubMed ID: 9112331 [TBL] [Abstract][Full Text] [Related]
26. Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130. Howlett M; Judd LM; Jenkins B; La Gruta NL; Grail D; Ernst M; Giraud AS Gastroenterology; 2005 Sep; 129(3):1005-18. PubMed ID: 16143138 [TBL] [Abstract][Full Text] [Related]
27. Down-regulation of expression of interleukin-6 and its receptor results in growth inhibition of MCF-7 breast cancer cells. Jiang XP; Yang DC; Elliott RL; Head JF Anticancer Res; 2011 Sep; 31(9):2899-906. PubMed ID: 21868536 [TBL] [Abstract][Full Text] [Related]
28. The effect of interleukin-17 on the proliferation and invasion of JEG-3 human choriocarcinoma cells. Pongcharoen S; Niumsup P; Sanguansermsri D; Supalap K; Butkhamchot P Am J Reprod Immunol; 2006 Apr; 55(4):291-300. PubMed ID: 16533341 [TBL] [Abstract][Full Text] [Related]
29. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes. Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404 [TBL] [Abstract][Full Text] [Related]
31. Interleukin 8 is an autocrine growth factor and a surrogate marker for Kaposi's sarcoma. Masood R; Cai J; Tulpule A; Zheng T; Hamilton A; Sharma S; Espina BM; Smith DL; Gill PS Clin Cancer Res; 2001 Sep; 7(9):2693-702. PubMed ID: 11555581 [TBL] [Abstract][Full Text] [Related]
32. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins. Blanchard F; Kinzie E; Wang Y; Duplomb L; Godard A; Held WA; Asch BB; Baumann H Oncogene; 2002 Sep; 21(41):6264-77. PubMed ID: 12214267 [TBL] [Abstract][Full Text] [Related]
33. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family. Montero-Julian FA; Brailly H; Sautès C; Joyeux I; Dorval T; Mosseri V; Yasukawa K; Wijdenes J; Adler A; Gorin I; Fridman WH; Tartour E Clin Cancer Res; 1997 Aug; 3(8):1443-51. PubMed ID: 9815830 [TBL] [Abstract][Full Text] [Related]
34. The N-terminus domain of the a2 isoform of vacuolar ATPase can regulate interleukin-1beta production from mononuclear cells in co-culture with JEG-3 choriocarcinoma cells. Ntrivalas E; Gilman-Sachs A; Kwak-Kim J; Beaman K Am J Reprod Immunol; 2007 Mar; 57(3):201-9. PubMed ID: 17295899 [TBL] [Abstract][Full Text] [Related]
35. Production of interleukin (IL)-6 and IL-8 by a choriocarcinoma cell line, BeWo. Fujisawa K; Nasu K; Arima K; Sugano T; Narahara H; Miyakawa I Placenta; 2000 May; 21(4):354-60. PubMed ID: 10833370 [TBL] [Abstract][Full Text] [Related]
36. Effect of IL-6 receptor antisense oligodeoxynucleotide on in vitro proliferation of myeloma cells. Keller ET; Ershler WB J Immunol; 1995 Apr; 154(8):4091-8. PubMed ID: 7706747 [TBL] [Abstract][Full Text] [Related]
37. Development of a monoclonal antibody-based enzyme-linked immunoabsorbent assay for the binding of gp130 to the IL-6/IL-6R complex and its competitive inhibition. Scheller J; Kovaleva M; Rabe B; Eichler J; Kallen KJ; Rose-John S J Immunol Methods; 2004 Aug; 291(1-2):93-100. PubMed ID: 15345308 [TBL] [Abstract][Full Text] [Related]
38. Interleukin 6 receptor superantagonists are potent inducers of human multiple myeloma cell death. Demartis A; Bernassola F; Savino R; Melino G; Ciliberto G Cancer Res; 1996 Sep; 56(18):4213-8. PubMed ID: 8797594 [TBL] [Abstract][Full Text] [Related]
39. Growth inhibition of human lung cancer cell lines by interleukin 6 in vitro: a possible role in tumor growth via an autocrine mechanism. Takizawa H; Ohtoshi T; Ohta K; Yamashita N; Hirohata S; Hirai K; Hiramatsu K; Ito K Cancer Res; 1993 Sep; 53(18):4175-81. PubMed ID: 8364912 [TBL] [Abstract][Full Text] [Related]
40. Interleukin 6 acts as a paracrine growth factor in human mammary carcinoma cell lines. Chiu JJ; Sgagias MK; Cowan KH Clin Cancer Res; 1996 Jan; 2(1):215-21. PubMed ID: 9816109 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]